Immunology & Rheumatology Clinical Trials

Statistical methods in immunology & rheumatology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All immunology & rheumatology trials

1,062 results

• Effects of 12-week Digital Treatment in Patients With Hand OA on Pain and Function: Complete Statistical AnalysisIndependent statistical analysis of Effects of 12-week Digital Treatment in Patients With Hand OA on Pain and Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 846NCT05499559
• Effects of a Rehabilitation Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis.: Complete Statistical AnalysisIndependent statistical analysis of Effects of a Rehabilitation Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 34NCT01307787
• Effects of Broccoli Sprout Extract on Allergy Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of Effects of Broccoli Sprout Extract on Allergy Rhinitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02885025).Phase 2Results postedn = 47NCT02885025
• Effects of Cladribine Tablets on the PK of Microgynon®: Complete Statistical AnalysisIndependent statistical analysis of Effects of Cladribine Tablets on the PK of Microgynon®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03745144).Phase 1Results postedn = 28NCT03745144
• Effects of Denosumab on the Pharmacokinetics of Etanercept: Complete Statistical AnalysisIndependent statistical analysis of Effects of Denosumab on the Pharmacokinetics of Etanercept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01294397).Phase 1Results postedn = 19NCT01294397
• Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045): Complete Statistical AnalysisIndependent statistical analysis of Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 14NCT02715700
• Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels: Complete Statistical AnalysisIndependent statistical analysis of Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04537715).Phase 1Results postedn = 42NCT04537715
• Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF): Complete Statistical AnalysisIndependent statistical analysis of Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 10NCT03126370
• Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01100658).Phase NAResults postedn = 1NCT01100658
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.: Complete Statistical AnalysisIndependent statistical analysis of Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 45NCT00446459
• Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 10NCT04261790
• Effects of Vaporized Marijuana on Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of Effects of Vaporized Marijuana on Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01037088).Phase 1/2Results postedn = 44NCT01037088
• Effects of Whole Sprouts on Airway Allergic Inflammation: Complete Statistical AnalysisIndependent statistical analysis of Effects of Whole Sprouts on Airway Allergic Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01522703).Phase NAResults postedn = 51NCT01522703
• Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00308308).Phase 3Results postedn = 589NCT00308308
• Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 2Results postedn = 355NCT01527188
• Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 403NCT01634139
• Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 465NCT01316380
• Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 105NCT01122680
• Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 158NCT01893905
• Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 373NCT02446899
• Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 78NCT02519387
• Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds: primary endpoint results, effect estimate with…Phase 3Results postedn = 782NCT00640822
• Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 4Results postedn = 139NCT00154297
• Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 528NCT01820585
• Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 60NCT02473965
• Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 4Results postedn = 29NCT00802737
• Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 49NCT00481676
• Efficacy and Safety of Omalizumab in Children (6 – < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 628NCT00079937
• Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02): Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02): primary endpoint results, effect estimate…Phase 3Results postedn = 49NCT01438840
• Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid in Patients With OA of the Knee: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Repeated Intraarticular Injections of Hyaluronic Acid in Patients With OA of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 446NCT00669032
• Efficacy and Safety of Single, Low-dose Dexamethasone in Patients After Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Single, Low-dose Dexamethasone in Patients After Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 291NCT01612702
• Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults: primary endpoint results,…Phase 3Results postedn = 224NCT01667731
• Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 168NCT02556801
• Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 169NCT00589979
• Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 388NCT00350207
• Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 18NCT00520494
• Efficacy and Safety Study in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study in Subjects With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00980200).Phase 2Results postedn = 75NCT00980200
• Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 91NCT00262080
• Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 833NCT00251004
• Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01353079).Phase 3Results postedn = 429NCT01353079
• Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 161NCT02531633
• Efficacy of 3 Weekly Injections of Hyaluronate in Patients With Ankle Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of 3 Weekly Injections of Hyaluronate in Patients With Ankle Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 46NCT00918736
• Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00768040).Phase 2Results postedn = 39NCT00768040
• Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 662NCT00640653
• Efficacy of Cooled and Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Cooled and Monopolar Radiofrequency Ablation of the Geniculate Nerves for the Treatment of Chronic Osteoarthritic Knee Pain: primary endpoint results, effect estimate with confidence interval, sample-size…Phase NAResults postedn = 79NCT02260869
• Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03379168).Phase NAResults postedn = 75NCT03379168
• Efficacy of Shinabro in Hand Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Shinabro in Hand Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01910116).Phase 2/3Results postedn = 220NCT01910116
• Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults: Complete Statistical AnalysisIndependent statistical analysis of Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults: primary endpoint results,…Phase 3Results postedn = 55NCT01967940
• Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02368093).Phase NAResults postedn = 48NCT02368093
• Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 129NCT03738423

← All therapeutic areas